- Home
- SLS vs SEVN Comparison
SLS vs SEVN Comparison
Compare SLS & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | SEVN |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 206.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | SEVN |
|---|---|---|
| Price | $3.61 | $8.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | ★ $12.13 |
| AVG Volume (30 Days) | ★ 5.6M | 110.1K |
| Earning Date | 03-19-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 12.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $29,408,000.00 |
| Revenue This Year | N/A | $0.59 |
| Revenue Next Year | N/A | $14.72 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $8.30 |
| 52 Week High | $5.18 | $13.44 |
Technical Indicators
Market Signals| Indicator | SLS | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 41.00 |
| Support Level | $3.46 | $8.60 |
| Resistance Level | $3.90 | $8.83 |
| Average True Range (ATR) | 0.33 | 0.18 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 4.96 | 41.32 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.